World's Best Scientists 2026 revealed!
Mario Rizzetto

Mario Rizzetto

D-Index & Metrics

Medicine

D-Index
107
Citations
56403
World Ranking
6135
National Ranking
191

Overview

Mario Rizzetto is affiliated with the University of Turin in Italy and has contributed extensively to medical research, focusing primarily on hepatitis viruses and liver diseases. Their scholarly work spans the fields of Medicine with specific emphasis on Epidemiology, Hepatology, Surgery, Genetics, and Infectious Diseases.

The scientist's research topics encompass a broad range of subjects related to viral hepatitis and liver pathology. Key areas include:

  • Hepatitis B Virus Studies
  • Hepatitis C virus research
  • Hepatitis Viruses Studies and Epidemiology
  • Liver Disease Diagnosis and Treatment
  • Cytomegalovirus and herpesvirus research
  • Influenza Virus Research Studies
  • Organ Transplantation Techniques and Outcomes

Mario Rizzetto has co-authored work with several frequent collaborators, including:

  • Gian Paolo Caviglia
  • Antonella Olivero
  • Ilaria Lenci
  • Elisabetta Teti
  • Lorenzo Piermatteo

Their publications are commonly found in journals specializing in liver and viral diseases. Notable publication venues include:

  • Journal of Hepatology
  • WikiJournal of Medicine
  • Viruses
  • Liver International
  • Biomedicines

Among recent scholarly contributions, the following papers authored or co-authored by Mario Rizzetto are notable:

  • The changing context of hepatitis D, 2021, Journal of Hepatology
  • Hepatitis D Virus Infection, 2023, New England Journal of Medicine
  • A Review of HDV Infection, 2022, Viruses
  • The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease, 2021, Journal of Advanced Research
  • Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022, 2023, JHEP Reports

Best Publications

  • Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

    Hadziyannis Sj;Sette H;Morgan Tr;Balan

  • Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

    Giulio Marchesini;Elisabetta Bugianesi;Gabriele Forlani;Fernanda Cerrelli

  • Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

    Ira M. Jacobson;John G. McHutchison;Geoffrey Dusheiko;Adrian M. Di Bisceglie

  • Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma

    Elisabetta Bugianesi;Nicola Leone;Ester Vanni;Giulio Marchesini

  • Complications following percutaneous liver biopsy: A multicentre retrospective study on 68 276 biopsies

    F. Piccinino;E. Sagnelli;G. Pasquale;G. Giusti

  • Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers.

    M Rizzetto;Mg Canese;S Arico;O Crivelli

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting–Tsung Chang

  • Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association

    Gianfranco Pagano;Giovanni Pacini;Giovanni Musso;Roberto Gambino

  • A Randomized Controlled Trial of Metformin versus Vitamin E or Prescriptive Diet in Nonalcoholic Fatty Liver Disease

    Elisabetta Bugianesi;Elena Gentilcore;Rita Manini;Stefania Natale

  • Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis

    Giovanni Musso;Roberto Gambino;Franco De Michieli;Maurizio Cassader

  • Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

    E. Bugianesi;A. Gastaldelli;E. Vanni;R. Gambino

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Oxford Textbook of Clinical Hepatology

    J Bircher;J.-P Benhamou;N McIntyre;M Rizzetto

  • TRANSMISSION OF THE HEPATITIS B VIRUS-ASSOCIATED DELTA ANTIGEN TO CHIMPANZEES

    M. Rizzetto;M. G. Canese;J. L. Gerin;W. T. London

  • delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees

    M. Rizzetto;B. Hoyer;M. G. Canese;J. W. K. Shih

  • Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

    Michael Manns;Didier Samuel;Edward J Gane;David Mutimer

  • The Delta Agent

    Mario Rizzetto

  • Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

    Elisabetta Bugianesi;Paola Manzini;Sergio D'Antico;Ester Vanni

  • INFLUENCE OF DELTA INFECTION ON SEVERITY OF HEPATITIS B

    Antonina Smedile;Giorgio Verme;Antonietta Cargnel;Pietro Dentico

Frequent Co-Authors

Elisabetta Bugianesi
Elisabetta Bugianesi University of Turin
Ferruccio Bonino
Ferruccio Bonino National Research Council (CNR)
Maurizio Cassader
Maurizio Cassader University of Turin
Alessandro Repici
Alessandro Repici Humanitas University
Amalia Gastaldelli
Amalia Gastaldelli National Research Council (CNR)
Angelo Andriulli
Angelo Andriulli Casa Sollievo della Sofferenza
Antonio Craxì
Antonio Craxì University of Palermo
Massimo Colombo
Massimo Colombo Humanitas University
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Stephanos J. Hadziyannis
Stephanos J. Hadziyannis National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering alternatives or complementary career paths to a traditional MD, exploring online degrees in healthcare is a strategic choice. Many prospective medical professionals find that advanced nursing degrees can lead to rewarding roles with greater flexibility.

Options such as fastest msn to dnp program options let registered nurses rapidly advance their qualification, boosting their potential for leadership and specialized roles. Others may prefer the affordability offered by cheapest online dnp programs, helping to reduce the financial burden while still achieving a Doctor of Nursing Practice degree.

Those looking to start their nursing journey quickly can benefit from lpn online programs, which focus on getting students workforce-ready in less time than traditional routes. Additionally, the mental health field is in high demand; the psychiatric np programs online offer a streamlined path into psychiatric nurse practitioner roles.

Exploring these related online degrees can provide flexible alternatives to medical school, enable career advancement, and address critical healthcare shortages.

Best Scientists Citing Mario Rizzetto

Trending Scientists

Recently Published Articles